The concurrent elevation of RIPK-3, particularly in adult sepsis patients, although not statistically significant in children, aligns with animal and experimental data indicating that activation of RIPK(1/3) exacerbates tissue injury [22,23,24], cytokine release, and necroptotic cell death in sepsis models [5,25]. The gene discussed is RIPK3; the disease is Sepsis.